Cargando…

KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in HLA-B Bw4 Homozygous Individuals

Bw4 homozygosity in human leukocyte antigen class B alleles has been associated with a delayed acquired immunodeficiency syndrome (AIDS) development and better control of human immunodeficiency virus type 1 (HIV-1) viral load (VL) than Bw6 homozygosity. Efficient CD8 T cell and natural killer (NK) c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xin, Lu, Xiaofan, Moog, Christiane, Yuan, Lin, Liu, Zhiying, Li, Zhen, Xia, Wei, Zhou, Yuefang, Wu, Hao, Zhang, Tong, Su, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096002/ https://www.ncbi.nlm.nih.gov/pubmed/30147699 http://dx.doi.org/10.3389/fimmu.2018.01855

Ejemplares similares

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
por: Erbe, Amy K., et al.
Publicado: (2019)

Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
por: Niepiekło-Miniewska, Wanda, et al.
Publicado: (2014)

The killer immunoglobulin-like receptor KIR3DL1 combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
por: Hollenbach, Jill A., et al.
Publicado: (2016)

HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19
por: Wang, Ruihua, et al.
Publicado: (2023)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC
por: Lisovsky, Irene, et al.
Publicado: (2019)

KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
por: Tapsoba, Aziz Sidi Aristide, et al.
Publicado: (2022)

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells
por: Sim, Malcolm J. W., et al.
Publicado: (2015)

In vitro education of human natural killer cells by KIR3DL1
por: Pugh, Jason, et al.
Publicado: (2019)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
por: Chrul, Slawomir, et al.
Publicado: (2006)

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
por: Moradi, Shoeib, et al.
Publicado: (2021)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han
por: Zhen, Jian Xin, et al.
Publicado: (2020)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
por: Morales, Raquel, et al.
Publicado: (2023)

Are the KIR3DS1homozygous and KIR3DL1*h/*y+HLA-B*57 genotypes associated protection from HIV by different routes of exposure?
por: Tallon, B, et al.
Publicado: (2012)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
por: Hirayasu, Kouyuki, et al.
Publicado: (2012)

Immunoinformatic Docking Approach for the Analysis of KIR3DL1/HLA-B Interaction
por: Grifoni, Alba, et al.
Publicado: (2013)

Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1
por: Harrison, Genelle F., et al.
Publicado: (2022)

KIR and HLA haplotype analysis in a family lacking the KIR 2DL1-2DP1 genes
por: Vojvodić, S, et al.
Publicado: (2015)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01
por: Salzberger, Wilhelm, et al.
Publicado: (2015)

Peptide selectivity discriminates NK cells from KIR2DL2‐ and KIR2DL3‐positive individuals
por: Cassidy, Sorcha, et al.
Publicado: (2014)

Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
por: La, David, et al.
Publicado: (2011)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
por: Euchner, Johanna, et al.
Publicado: (2021)

Homozygous KIR2DL3 confers susceptibility to tuberculosis infection in HIV seropositive individuals
por: Maruthamuthu, Stalinraja, et al.
Publicado: (2014)

Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma
por: Muriuki, Beatrice M., et al.
Publicado: (2023)

Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients
por: Sezgin, Gülay, et al.
Publicado: (2022)

Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease
por: Castaño-Núñez, Ángel, et al.
Publicado: (2019)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

Regulation of KIR3DL3 Expression via miRNA
por: Nutalai, Rungtiwa, et al.
Publicado: (2019)

The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis
por: Nishimura, Wester Eidi, et al.
Publicado: (2015)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function
por: D’Amico, Silvia, et al.
Publicado: (2021)

异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
Publicado: (2017)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

Single Nucleotide Polymorphism in KIR2DL1 Is Associated With HLA-C Expression in Global Populations
por: Vargas, Luciana de Brito, et al.
Publicado: (2020)

Protective genotypes in HIV infection reflect superior function of KIR3DS1(+) over KIR3DL1(+) CD8(+) T cells
por: Zipperlen, Katrin, et al.
Publicado: (2014)

KIR2DL4 (CD158d): An activation receptor for HLA-G
por: Rajagopalan, Sumati, et al.
Publicado: (2012)

Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
por: Zheng, Guoxu, et al.
Publicado: (2022)

Characterization of KIR (+) NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C
por: Meazza, Raffaella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7junp3gpg9ps2s3svu7p6cv3i7